51. Recurrent acute interstitial nephritis: what lies beneath
- Author
-
Caravaca Fontán, Fernando, Shabaka, Amir, Sánchez Álamo, Beatriz, Lorenzo, Alberto de, Díaz, Martha, Blasco Pelícano, Miquel, Rodríguez, Eva, Sierra Carpio, Milagros, Malek Marín, Tamara, Urrestarazú, Andrés, Corona Cases, Clara, Praga, Manuel, Fernández Juárez, Gema, and Spanish Group for the Study of Glomerular Diseases (GLOSEN)
- Subjects
Nephrology ,medicine.medical_specialty ,Interstitial nephritis ,030232 urology & nephrology ,Tubulointerstitial nephritis and uveitis ,recurrent acute interstitial nephritis ,Azathioprine ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,AcademicSubjects/MED00340 ,Transplantation ,business.industry ,Original Articles ,medicine.disease ,Etiology ,acute interstitial nephritis ,Sarcoidosis ,business ,chronic kidney disease ,Kidney disease ,Cohort study ,medicine.drug - Abstract
Background Acute interstitial nephritis (AIN) is an emerging cause of acute kidney disease. While this disease usually follows an acute course, it may occasionally recur, representing a major challenge for the clinician. Methods We performed a retrospective, observational cohort study in 13 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases. Patients with biopsy-proven AIN between 1996 and 2018 were included. Results The study group consisted of 205 patients with AIN, 22 of which developed recurrent AIN (RAIN) after a median of 111 days from diagnosis. RAIN was due to a surreptitious reintroduction of a previously known implicated drug or toxic in six patients (27%), sarcoidosis in two (9%), Sjögren’s syndrome in three (14%), light-chain-mediated AIN in two (9%) and tubulointerstitial nephritis and uveitis syndrome in two (9%), while in the rest of cases (32%), no precise cause could be identified. Microscopic haematuria was more frequent in patients with underlying systemic diseases. The first RAIN episode was treated with a repeated course of corticosteroids in 21 patients (95%). In six cases (27%), azathioprine and mycophenolate mofetil were added as corticosteroid-sparing agents. During a median follow-up of 30 months, 50 patients (27%) with no recurrences and 12 patients (55%) with RAIN reached Stages 4 and 5 chronic kidney disease (CKD). By multivariable logistic regression analysis, RAIN was independently associated with the risk of reaching Stages 4 and 5 CKD, even after adjusting for potential covariables. Conclusions RAIN is infrequent but is associated with poor kidney survival. RAIN should prompt clinicians to search for an underlying aetiology other than drug induced. However, in a large percentage of cases, no precise cause can be identified.
- Published
- 2020